Patent: 9,279,001
✉ Email this page to a colleague
Summary for Patent: 9,279,001
Title: | Injection paradigm for administration of botulinum toxins |
Abstract: | Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine. |
Inventor(s): | Turkel; Catherine C. (Newport Coast, CA), Aurora; Sheena K. (Seattle, WA), Brin; Mitchell F. (Newport Beach, CA) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 13/863,522 |
Patent Claims: | see list of patent claims |
Details for Patent 9,279,001
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ipsen Biopharm Limited | DYSPORT | abobotulinumtoxina | For Injection | 125274 | 04/29/2009 | ⤷ Try a Trial | 2030-03-30 |
Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | 07/30/2010 | ⤷ Try a Trial | 2030-03-30 |
Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | 11/20/2015 | ⤷ Try a Trial | 2030-03-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |